Straumann Holding AG (XSWX:STMN) Tariff Resilience Score: 8/10 (As of Jun. 27, 2026)


XSWX:STMN Straumann Holding AG XSWX:STMN
98 GF Score
Price CHF106.35
GF Value CHF136.92
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Straumann Holding AG Tariff Resilience Score?

Straumann Holding AG XSWX:STMN -0.42% 98 Tariff Resilience Score is 8 as of Jun. 27, 2026. GuruFocus rates XSWX:STMN with a GF Score™ of 98/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 99.64% on this metric.

Straumann Holding AG has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Straumann Holding AG has Straumann's global dental solutions business benefits from industry-specific exemptions. Its diversified manufacturing and sales markets, along with strong pricing power, provide high resilience against tariffs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Straumann Holding AG might have Highly Resilient.

Straumann Holding AG  (XSWX:STMN) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Straumann Holding AG Tariff Resilience Score Related Terms

XSWX:STMN vs ISRG, BDX, MDLN: Tariff Resilience Score Comparison

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Straumann Holding AG Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's Tariff Resilience Score falls into.


XSWX:STMN
98GF Score
Straumann Holding AG XSWX:STMN
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Straumann Holding AG (XSWX:STMN) has a Tariff Resilience Score of 8 as of Jun. 27, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Straumann Holding AG ranks #3 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 0.40000000000001%.
Is Straumann Holding AG's Tariff Resilience Score too high?
Straumann Holding AG's current Tariff Resilience Score is 8. Based on the distribution chart, Straumann Holding AG ranks #3 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Straumann Holding AG has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Tariff Resilience Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #3 out of 838 companies for Tariff Resilience Score. This places Straumann Holding AG in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Straumann Holding AG's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.35 — trading 22.3% below its estimated fair value. The current Tariff Resilience Score is 8. Straumann Holding AG's overall GF Score™ is 98/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Tariff Resilience Score is 8 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?

Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued. The current stock price of CHF106.35 is trading 22.3% below its estimated GF Value™ of CHF136.92. GuruFocus considers Straumann Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:STMN:

  • Tariff Resilience Score: 8
  • GF Value™: CHF136.92 vs. price of CHF106.35 (22.3% below fair value)
  • GF Score™: 98/100 with 7 warning signs

No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Straumann Holding AG Business Description

Address Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
98GF Score

Get the complete analysis for XSWX:STMN

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF106.35
Price
CHF136.92
GF Value